Generated: April 28, 2017
|Title:||Oral pharmaceutical preparation containing ibandronat|
|Abstract:||The invention is directed to well-tolerated pharmaceutical compositions for oral application, containing ibandronate or a physiologically tolerable salt thereof as active substance, the administration form consisting of an active substance-containing inner portion enclosed in such fashion by a coat free of active substance that rapid release of the active substance takes place.|
|Inventor(s):||Mockel; Jorn (Heidelberg, DE), Gabel; Rolf-Dieter (Schwetzingen, DE), Woog; Heinrich (Laudenbach, DE)|
|Assignee:||Roche Diagnostics GmbH (Mannheim, DE)|
1. A method of treating a bone disease in a patient in need thereof, comprising orally administering to the patient a pharmaceutical formulation comprising a tablet core
containing about 0.1 to 100 mg of ibandronate and a coating which is free of ibandronate and has the following proportional composition:
(a) about 51.425% by weight of methylhydroxypropylcellulose;
(b) about 24.650% by weight of titanium dioxide;
(c) about 15.000% by weight of polyethylene glycol; and
(d) about 8.925% by weight of talc.
2. The method of claim 1, wherein the bone disease is related to a disorder in calcium metabolism.
3. The method of claim 1, wherein the bone disease is selected from the group consisting of hypercalcemia, osteoporosis, tumor osteolysis, and Paget's disease.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.